ConductScience.org, home

Paper31369045

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Garcia-Murillas I and 21 others. JAMA Oncol, 2019. Cited by 351 papers, by iCite.

Cite this record

ConductScience Library. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer. Papers, record 31369045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31369045

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
PubMed
Journal
JAMA Oncol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Multicenter Study, Validation Study
PubMed
Citations, by iCite
351
iCite
Relative citation ratio, by iCite
11.7
iCite
Revised in PubMed
2025-05-30
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garcia-Murillas IIsaac
2Chopra NNeha
3Comino-Méndez IIñaki
4Beaney MMatthew
5Tovey HHolly
6Cutts RJRosalind J
7Swift CClaire
8Kriplani DDivya
9Afentakis MMaria
10Hrebien SSarah
11Walsh-Crestani GGiselle
12Barry PPeter
13Johnston SRDStephen R D
14Ring AAlistair
15Bliss JJudith
16Russell SSimon
17Evans AAbigail
18Skene AAnthony
19Wheatley DDuncan
20Dowsett MMitch

Source PubMed

See all 22 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Circulating Tumor DNAMajor topic
Neoplasm Recurrence, LocalMajor topic
Adult
Aged
Biomarkers, Tumor
Female
Humans
Middle Aged
Mutation
Recurrence

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
25351Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04985266
A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
BackgroundClinicalTrials.gov
NCT05058183Safe De-escalation of Chemotherapy for Stage 1 Breast CancerBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in31917389Errors in Results.https://conductscience.org/library/papers/31917389PubMed
Comment in31855227Clinical Benefit of Circulating Tumor DNA Analysis in Early-Stage Breast Cancer.https://conductscience.org/library/papers/31855227PubMed
Comment in31855255Clinical Benefit of Circulating Tumor DNA Analysis in Follow-up of Patients With Early-Stage Breast Cancer-Reply.https://conductscience.org/library/papers/31855255PubMed

Download CSV of comments and corrections

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129601269Molecular Minimal Residual Disease in Acute Myeloid Leukemia.N Engl J Med2018https://conductscience.org/library/papers/29601269PubMed
226311728Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.Sci Transl Med2015https://conductscience.org/library/papers/26311728PubMed
326789727Assessment of Minimal Residual Disease in Standard-Risk AML.N Engl J Med2016https://conductscience.org/library/papers/26789727PubMed
429504847Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.J Clin Oncol2018https://conductscience.org/library/papers/29504847PubMed
529567812False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.Clin Cancer Res2018https://conductscience.org/library/papers/29567812PubMed
625326804Age-related mutations associated with clonal hematopoietic expansion and malignancies.Nat Med2014https://conductscience.org/library/papers/25326804PubMed
728445469Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.Nature2017https://conductscience.org/library/papers/28445469PubMed
825654990Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.Gut2016https://conductscience.org/library/papers/25654990PubMed
925426838Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.N Engl J Med2014https://conductscience.org/library/papers/25426838PubMed
1028899864Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.Cancer Discov2017https://conductscience.org/library/papers/28899864PubMed
1126554728Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.Nat Commun2015https://conductscience.org/library/papers/26554728PubMed
1227384348Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.Sci Transl Med2016https://conductscience.org/library/papers/27384348PubMed
1325987569Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.EMBO Mol Med2015https://conductscience.org/library/papers/25987569PubMed
1424627271Promoting quality and evidence-based care in early-stage breast cancer follow-up.J Natl Cancer Inst2014https://conductscience.org/library/papers/24627271PubMed
1524553385Detection of circulating tumor DNA in early- and late-stage human malignancies.Sci Transl Med2014https://conductscience.org/library/papers/24553385PubMed

Download CSV of references

Cited by234

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 351 citations.

PMIDTitleJournalYearIn PapersSource
42958365Dynamic ctDNA-MRD in breast cancer: subtype-specific implications for perioperative decision-making, postoperative surveillance, and MRD-guided therapy.World J Surg Oncol2026https://conductscience.org/library/papers/42958365PubMed
42938935Clinical Challenges in Triple-Negative Breast Cancer (TNBC): Current Treatment Options, Their Limitations, and Emerging Perspectives.Cancers (Basel)2026https://conductscience.org/library/papers/42938935PubMed
42911423The right patient, the right moment, the right therapy: reimagining precision oncology from the bedside.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42911423PubMed
42724567Assessing the utility of ctDNA as a prognostic marker in advanced ER-positive/HER2-negative breast cancer.Transl Cancer Res2026https://conductscience.org/library/papers/42724567PubMed
42645355Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer.Curr Oncol2026https://conductscience.org/library/papers/42645355PubMed
42582727Current perspectives on circulating tumor DNA in breast cancer: a narrative review.Transl Breast Cancer Res2026https://conductscience.org/library/papers/42582727PubMed
42558411Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy.Front Oncol2026https://conductscience.org/library/papers/42558411PubMed
42508231Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias.EBioMedicine2026https://conductscience.org/library/papers/42508231PubMed
42504045Applications of Artificial Intelligence in Cancer Diagnosis and Treatment.Cancer Med2026https://conductscience.org/library/papers/42504045PubMed
42472109The role of serologic biomarkers "liquid biopsy" in the fight against breast cancer: From biological foundations to clinical impact.iScience2026https://conductscience.org/library/papers/42472109PubMed
42430497A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.Sci Adv2026https://conductscience.org/library/papers/42430497PubMed
42421646Circulating tumor DNA in early breast cancer: Evidence, challenges, next steps.Cancer2026https://conductscience.org/library/papers/42421646PubMed
42401541Unlocking the ferroptotic window: Lipidomic rewiring and metabolic addiction in EMT-driven breast cancer resistance.Cell Death Discov2026https://conductscience.org/library/papers/42401541PubMed
42324681Personalized whole-genome-based ctDNA dynamics during neoadjuvant therapy across breast cancer subtypes: results from MONITOR-Breast.Future Oncol2026https://conductscience.org/library/papers/42324681PubMed
42299414The complete treatment and management of brain metastases in a patient with limited-stage small cell lung cancer under molecular residual disease (MRD) monitoring: a case report.AME Case Rep2026https://conductscience.org/library/papers/42299414PubMed
42250175Integrating multi-omics and clinical management in breast cancer: a comprehensive review.Discov Oncol2026https://conductscience.org/library/papers/42250175PubMed
42242004Tracking structural variants in early breast cancer using a high-sensitivity ctDNA assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial.ESMO Open2026https://conductscience.org/library/papers/42242004PubMed
42161983Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.NPJ Breast Cancer2026https://conductscience.org/library/papers/42161983PubMed
42016861Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow-up strategies.Bioeng Transl Med2026https://conductscience.org/library/papers/42016861PubMed
42003932Biological basis and clinical translation prospects of circulating cell-free DNA in precision management of breast cancer (Review).Oncol Lett2026https://conductscience.org/library/papers/42003932PubMed

See all 234 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31369045

GET https://conductscience.org/api/papers/v1/31369045/authors?page=2